Literature DB >> 16048490

Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells.

S Kamihira1, K Sugahara, K Tsuruda, S Minami, A Uemura, N Akamatsu, H Nagai, K Murata, H Hasegawa, Y Hirakata, Y Takasaki, K Tsukasaki, Y Yamada.   

Abstract

Human T-cell leukemia virus type-1 (HTLV-1) is the etiological agent of adult T-cell leukemia (ATL), and leukemic cells always carry the proviral genome monoclonally integrated into their host genomes at the same sequence site, designated as the monoclonal integration. Using Southern blot hybridization (SBH) and sequenced tagged site polymerase chain reaction assays, we examined the proviral status in 558 clinical specimens from 350 patients who are suspected to have ATL. A total of 321 specimens (57.5%) from 241 patients showed positive results for the monoclonal integration according to SBH, using EcoR1 and Pst1. The 241 patients consisted of 136 patients (56.4%) with the complete provirus (C-type), 62 patients (25.7%) with a defective provirus (D-type), and 43 patients (17.8%) with multibands (M-type). The incidence of the D- and M-types were in the order of smoldering, chronic, and acute subtypes of ATL, suggesting that such an aberrant proviral status is generated on the way to multistep carcinogenesis and is subsequently clinically important for the malignant behavior of the disease. Moreover, our data showed that the partial deletion of the proviral genome is initiated first at the site of the gag region and spreads into the sites of the pol and env regions, whereas the long terminal repeats and pX regions are almost always conserved. These results suggest that analysis of the proviral status provides useful diagnostic and virologic-oncological information about ATL and HTLV-1 pathology, especially the important role of pX gene in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16048490     DOI: 10.1111/j.1365-2257.2005.00698.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  27 in total

1.  Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia: continuity from carrier status to smoldering ATL.

Authors:  Shimeru Kamihira; Masako Iwanaga; Yuko Doi; Daisuke Sasaki; Sayaka Mori; Kazuto Tsurda; Kazuhiro Nagai; Naoki Uno; Hiroo Hasegawa; Katsunori Yanagihara; Yoshitomo Morinaga; Kunihiro Tsukasaki; Hiroaki Taniguchi
Journal:  Int J Hematol       Date:  2012-03-28       Impact factor: 2.490

2.  Infection of defective human T-lymphotropic virus type 1.

Authors:  Yuuki Hashikura; Kazumi Umeki; Kunihiko Umekita; Hajime Nomura; Akiteru Yamada; Ikuo Yamamoto; Hiroo Hasegawa; Katsunori Yanagihara; Akihiko Okayama
Journal:  Hum Cell       Date:  2017-01-09       Impact factor: 4.174

3.  Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia.

Authors:  Sanaz Firouzi; Amir Farmanbar; Kenta Nakai; Masako Iwanaga; Kaoru Uchimaru; Atae Utsunomiya; Yutaka Suzuki; Toshiki Watanabe
Journal:  Blood Adv       Date:  2017-06-27

4.  Transition of adult T-cell leukemia/lymphoma clones during clinical progression.

Authors:  Sakura Aoki; Sanaz Firouzi; Yosvany López; Tadanori Yamochi; Kazumi Nakano; Kaoru Uchimaru; Atae Utusnomiya; Masako Iwanaga; Toshiki Watanabe
Journal:  Int J Hematol       Date:  2016-07-06       Impact factor: 2.490

5.  Adult T-cell leukemia in a liver transplant recipient that did not progress after onset of graft rejection.

Authors:  Shinsuke Suzuki; Kimiharu Uozumi; Masahiko Maeda; Yoshiko Yamasuji; Shin-ichi Hashimoto; Yasuji Komorizono; Satsuki Owatari; Masahito Tokunaga; Kouichi Haraguchi; Naomichi Arima
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 6.  Adult T-cell leukemia/lymphoma and HTLV-1.

Authors:  Renaud Mahieux; Antoine Gessain
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

7.  The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones.

Authors:  Nicolas A Gillet; Nirav Malani; Anat Melamed; Niall Gormley; Richard Carter; David Bentley; Charles Berry; Frederic D Bushman; Graham P Taylor; Charles R M Bangham
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

8.  High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders.

Authors:  Daisuke Sasaki; Yuko Doi; Hiroo Hasegawa; Katsunori Yanagihara; Kunihiro Tsukasaki; Masako Iwanaga; Yasuaki Yamada; Toshiki Watanabe; Shimeru Kamihira
Journal:  Virol J       Date:  2010-04-28       Impact factor: 4.099

9.  The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines.

Authors:  Yuuki Hashikura; Kazumi Umeki; Kunihiko Umekita; Hajime Nomura; Ikuo Yamamoto; Hiroo Hasegawa; Katsunori Yanagihara; Akihiko Okayama
Journal:  Hum Cell       Date:  2016-03-03       Impact factor: 4.174

10.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Mineki Saito; Toshio Matsuzaki; Yorifumi Satou; Jun-Ichirou Yasunaga; Kousuke Saito; Kimiyoshi Arimura; Masao Matsuoka; Yoshiro Ohara
Journal:  Retrovirology       Date:  2009-02-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.